Drug intelligence / Profile preview

Dexolyte

Development stage: Unknown
Lead developer: Navana Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Dexolyte is a veterinary electrolyte and nutritional supplement developed and manufactured by Navana Pharmaceuticals. It is formulated as a water-soluble powder containing sodium bicarbonate, sodium chloride, potassium chloride, vitamin A, and dextrose anhydrous. Dexolyte is indicated for poultry and other animals to maintain fluid, electrolyte, and acid-base balance. It is used to treat and prevent dehydration and electrolyte depletion associated with watery diarrhea, vomiting, metabolic acidosis, and transportation stress (particularly in day-old chicks). The formulation helps restore essential minerals, supports muscle and nerve function, and promotes feed conversion and weight gain.

Brand names: Dexolyte
Other names: Dexolyte Powderdextrose + potassium chloride + sodium bicarbonate + sodium chloride + vitamin A

Beyond the preview

Go deeper on Dexolyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dexolyte.